Seeking men and women with relapsing multiple sclerosis for a study of how effective and safe an investigational drug is compared to the usual treatment.
Participants in this study will be randomly assigned to get either the investigational drug or the standard drug used to treat relapsing multiple sclerosis. At the end of the investigational treatment period, participants will have the option of joining an extension study in which all participants will get the investigational drug.
What we're hoping for
We are studying whether an investigational drug is safe and effective in reducing relapses compared to the standard drug for relapsing multiple sclerosis.
ClinicalTrials.gov Identifier: NCT04338022